Oliver Broom

Oliver Broom has a diverse work experience. In 2021, they became a Senior Scientist High Throughput Screening at Skyhawk Therapeutics. From 2016 to 2021, they worked at Sanofi as a Research Scientist, Immuno-Oncology- management of projects and personal, where they managed industrial projects and personal, supervised research assistants and students, and executed and analyzed experiments. Oliver also presented projects to key stakeholders and upper management, and initiated and coordinated external innovation projects. From 2012 to 2016, they were a Post Doctoral Researcher at Umeå University. In 2010, they worked at Krahbichler Intellectual Property Advisors AB as a Patent Attorney. In 2009, they were a Research Scientist at Santaris Pharma, and in 2008, they were a Post Doctoral Researcher at Herlev Hospital.

Oliver Broom received their PhD in Cell Pathology from Lund University in 2007, having started their studies there in 2002.